BackNextGen Healthcare Overview

NextGen Healthcare Other Current Liabilities

Latest other current liabilities for NXGN: $77M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$76.87M
50.79% YoYΔ $-79.33M vs prior year quarter

Peer trimmed avg / median

Loading

NextGen Healthcare Other Current Liabilities History

Loading

NextGen Healthcare vs. peers: Other Current Liabilities Comparison

Loading

NextGen Healthcare Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NextGen Healthcare (NXGN) FAQ

The latest other current liabilities for NXGN is $77M as of September 2023. That compares with $160M in the prior-year period — down 50.8% year over year. Investors often review this figure alongside NextGen Healthcare's historical trend and sector peers before judging valuation or financial health.

Over the past year, NXGN's other current liabilities moved from $160M to $77M — a 50.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NextGen Healthcare's operating scale or balance-sheet position.

A other current liabilities figure of $77M for NXGN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NXGN's other current liabilities ($77M), review year-over-year change from $160M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack NextGen Healthcare's other current liabilities against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.